Performance Shipping (PSHG) had the worst year in 2017 by a micro-cap US stock in 2017, returning -100%.
| ASSET | YEAR | % RETURN |
|---|---|---|
Performance Shipping (PSHG) | 2017 | -99.98% |
American Resources Corp Class A (AREC) | 2017 | -99.67% |
Reliance Global (RELI) | 2017 | -99.51% |
Golden Matrix (GMGI) | 2017 | -99.33% |
Atlas Lithium Corporation Common Stock (ATLX) | 2017 | -99.2% |
Creative Medical Technology (CELZ) | 2017 | -97.09% |
Nocera (NCRA) | 2017 | -96.53% |
LiveOne (LVO) | 2017 | -95.11% |
InspireMD (NSPR) | 2017 | -94.84% |
Mawson Infrastructure (MIGI) | 2017 | -93% |
SenesTech (SNES) | 2017 | -91.48% |
Aytu BioScience (AYTU) | 2017 | -90.71% |
My Size (MYSZ) | 2017 | -87.04% |
Cardiff Oncology (CRDF) | 2017 | -85.58% |
Precipio (PRPO) | 2017 | -85.45% |
Aqua Metals (AQMS) | 2017 | -83.95% |
Beyond Air (XAIR) | 2017 | -83.37% |
Microbot Medical (MBOT) | 2017 | -83.28% |
Foremost Lithium Resource & Technology Ltd Common stock (FMST) | 2017 | -83.14% |
Biocardia (BCDA) | 2017 | -82.2% |
CPI Card (PMTS) | 2017 | -81.78% |
Atossa Genetics (ATOS) | 2017 | -81.21% |
Plus Therapeutics (PSTV) | 2017 | -80.65% |
Intellinetics (INLX) | 2017 | -80% |
Curis (CRIS) | 2017 | -77.78% |
Micro-cap stocks are treated as having a market cap of <= $300M.
